Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-10-08

Clinical Trial Update: GnRH Antagonist Pre-treatment for the Prevention of Asynchronous Follicular Growth [Phase 4]

View source ↗

Summary

Phase 4 trial update investigating GnRH antagonist pre-treatment to prevent asynchronous follicular growth in IVF.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • GnRH antagonist pre-treatment

Snippet

Sponsor: Assaf-Harofeh Medical Center | Conditions: IVF | Phase 4 | Status: UNKNOWN